175 related articles for article (PubMed ID: 25189867)
1. Recombinant human TSH and radioactive iodine therapy in the management of benign multinodular goiter.
Graf H
Eur J Endocrinol; 2015 Feb; 172(2):R47-52. PubMed ID: 25189867
[TBL] [Abstract][Full Text] [Related]
2. Single, very low dose (0.03 mg) of recombinant human thyrotropin (rhTSH) effectively increases radioiodine uptake in the I-131 treatment of large nontoxic multinodular goiter.
Mojsak MN; Abdelrazek S; Szumowski P; Rogowski F; Sykała M; Kostecki J; Kociura-Sawicka A; Jurgilewicz D; Myśliwiec J
Nucl Med Rev Cent East Eur; 2016; 19(1):3-11. PubMed ID: 26841373
[TBL] [Abstract][Full Text] [Related]
3. Human recombinant TSH preceding a therapeutic dose of radioiodine for multinodular goiters has no significant effect in the surge of TSH-receptor and TPO antibodies.
Rubio IG; Perone BH; Silva MN; Knobel M; Medeiros-Neto G
Thyroid; 2005 Feb; 15(2):134-9. PubMed ID: 15753672
[TBL] [Abstract][Full Text] [Related]
4. High prevalence of side effects after recombinant human thyrotropin-stimulated radioiodine treatment with 30 mCi in patients with multinodular goiter and subclinical/clinical hyperthyroidism.
Romão R; Rubio IG; Tomimori EK; Camargo RY; Knobel M; Medeiros-Neto G
Thyroid; 2009 Sep; 19(9):945-51. PubMed ID: 19678745
[TBL] [Abstract][Full Text] [Related]
5. Evaluation and management of multinodular goiter.
Hurley DL; Gharib H
Otolaryngol Clin North Am; 1996 Aug; 29(4):527-40. PubMed ID: 8844728
[TBL] [Abstract][Full Text] [Related]
6. Safety and efficacy of administering 0.2 mg of recombinant human TSH for two consecutive days as an adjuvant to therapy with low radioiodine doses in elderly out-patients with large nontoxic multinodular goiter.
Giusti M; Cappi C; Santaniello B; Ceresola E; Augeri C; Lagasio C; Minuto F
Minerva Endocrinol; 2006 Sep; 31(3):191-209. PubMed ID: 17213787
[TBL] [Abstract][Full Text] [Related]
7. Recombinant human thyrotropin stimulation prior to
Azorín Belda MJ; Martínez Caballero A; Figueroa Ardila GC; Martínez Ramírez M; Gómez Jaramillo CA; Dolado Ardit JI; Verdú Rico J
Rev Esp Med Nucl Imagen Mol; 2017; 36(1):7-12. PubMed ID: 27422154
[TBL] [Abstract][Full Text] [Related]
8. Time to reconsider nonsurgical therapy of benign non-toxic multinodular goitre: focus on recombinant human TSH augmented radioiodine therapy.
Fast S; Nielsen VE; Bonnema SJ; Hegedüs L
Eur J Endocrinol; 2009 Apr; 160(4):517-28. PubMed ID: 19106244
[TBL] [Abstract][Full Text] [Related]
9. [The use for recombinant human TSH in patients with toxic and non-toxic nodular goiter].
Jedrzejuk D; Milewicz A
Postepy Hig Med Dosw (Online); 2005 May; 59():188-92. PubMed ID: 15928602
[TBL] [Abstract][Full Text] [Related]
10. Low-dose recombinant human thyrotropin-aided radioiodine treatment of large, multinodular goiters in elderly patients.
Cohen O; Ilany J; Hoffman C; Olchovsky D; Dabhi S; Karasik A; Goshen E; Rotenberg G; Zwas ST
Eur J Endocrinol; 2006 Feb; 154(2):243-52. PubMed ID: 16452537
[TBL] [Abstract][Full Text] [Related]
11. Effect of 30 mCi radioiodine on multinodular goiter previously treated with recombinant human thyroid-stimulating hormone.
Paz-Filho GJ; Mesa-Junior CO; Olandoski M; Woellner LC; Goedert CA; Boguszewski CL; Carvalho GA; Graf H
Braz J Med Biol Res; 2007 Dec; 40(12):1661-70. PubMed ID: 17934635
[TBL] [Abstract][Full Text] [Related]
12. Radioiodine plus recombinant human thyrotropin do not cause acute airway compression and are effective in reducing multinodular goiter.
Albino CC; Graf H; Paz-Filho G; Diehl LA; Olandoski M; Sabbag A; Buchpiguel C
Braz J Med Biol Res; 2010 Mar; 43(3):303-9. PubMed ID: 20401438
[TBL] [Abstract][Full Text] [Related]
13. Pretreatment with a single, low dose of recombinant human thyrotropin allows dose reduction of radioiodine therapy in patients with nodular goiter.
Nieuwlaat WA; Huysmans DA; van den Bosch HC; Sweep CG; Ross HA; Corstens FH; Hermus AR
J Clin Endocrinol Metab; 2003 Jul; 88(7):3121-9. PubMed ID: 12843153
[TBL] [Abstract][Full Text] [Related]
14. Radioiodine 131I treatment for large nodular goiter: recombinant human thyrotropin allows the reduction of radioiodine 131I activity to be administered in patients with low uptake.
Ceccarelli C; Antonangeli L; Brozzi F; Bianchi F; Tonacchera M; Santini P; Mazzeo S; Bencivelli W; Pinchera A; Vitti P
Thyroid; 2011 Jul; 21(7):759-64. PubMed ID: 21568727
[TBL] [Abstract][Full Text] [Related]
15. An outline concerning the potential use of recombinant human thyrotropin for improving radioiodine therapy of multinodular goiter.
Medeiros-Neto G; Marui S; Knobel M
Endocrine; 2008 Apr; 33(2):109-17. PubMed ID: 18491237
[TBL] [Abstract][Full Text] [Related]
16. Recombinant human thyrotropin stimulated
Tang L; Ma T; Wu F
Nuklearmedizin; 2016 Dec; 55(6):228-235. PubMed ID: 27480576
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular assessment of hyperthyroid patients with multinodular goiter before and after radioiodine treatment preceded by stimulation with recombinant human TSH.
Barca MF; Gruppi C; Oliveira MT; Romão R; Cárdia MS; Rubio I; Knobel M; Medeiros-Neto G
Endocrine; 2007 Oct; 32(2):175-81. PubMed ID: 18026694
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of various doses of recombinant human thyrotropin in patients with multinodular goiters.
Braverman L; Kloos RT; Law B; Kipnes M; Dionne M; Magner J
Endocr Pract; 2008 Oct; 14(7):832-9. PubMed ID: 18996810
[TBL] [Abstract][Full Text] [Related]
19. Postintervention serum TSH levels may be useful to differentiate patients who should undergo levothyroxine suppressive therapy after thyroid surgery for multinodular goiter in a region with moderate iodine deficiency.
Rotondi M; Amato G; Del Buono A; Mazziotti G; Manganella G; Biondi B; Sinisi AM; Santini L; Bellastella A; Carella C
Thyroid; 2000 Dec; 10(12):1081-5. PubMed ID: 11201853
[TBL] [Abstract][Full Text] [Related]
20. Long-term efficacy of modified-release recombinant human thyrotropin augmented radioiodine therapy for benign multinodular goiter: results from a multicenter, international, randomized, placebo-controlled, dose-selection study.
Fast S; Hegedüs L; Pacini F; Pinchera A; Leung AM; Vaisman M; Reiners C; Wemeau JL; Huysmans DA; Harper W; Rachinsky I; de Souza HN; Castagna MG; Antonangeli L; Braverman LE; Corbo R; Düren C; Proust-Lemoine E; Marriott C; Driedger A; Grupe P; Watt T; Magner J; Purvis A; Graf H
Thyroid; 2014 Apr; 24(4):727-35. PubMed ID: 24341527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
